- Home
- VYX vs ARWR Comparison
VYX vs ARWR Comparison
Compare VYX & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYX
- ARWR
- Stock Information
- Founded
- VYX 1881
- ARWR 2003
- Country
- VYX United States
- ARWR United States
- Employees
- VYX N/A
- ARWR N/A
- Industry
- VYX
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- VYX
- ARWR Health Care
- Exchange
- VYX Nasdaq
- ARWR Nasdaq
- Market Cap
- VYX 1.5B
- ARWR 1.8B
- IPO Year
- VYX N/A
- ARWR 1993
- Fundamental
- Price
- VYX $11.60
- ARWR $15.32
- Analyst Decision
- VYX Strong Buy
- ARWR Buy
- Analyst Count
- VYX 5
- ARWR 8
- Target Price
- VYX $14.40
- ARWR $43.71
- AVG Volume (30 Days)
- VYX 1.5M
- ARWR 1.5M
- Earning Date
- VYX 08-05-2025
- ARWR 08-07-2025
- Dividend Yield
- VYX N/A
- ARWR N/A
- EPS Growth
- VYX N/A
- ARWR N/A
- EPS
- VYX 6.72
- ARWR N/A
- Revenue
- VYX $2,733,000,000.00
- ARWR $545,209,000.00
- Revenue This Year
- VYX N/A
- ARWR $21,924.50
- Revenue Next Year
- VYX N/A
- ARWR N/A
- P/E Ratio
- VYX $1.72
- ARWR N/A
- Revenue Growth
- VYX N/A
- ARWR 1436.97
- 52 Week Low
- VYX $7.55
- ARWR $9.57
- 52 Week High
- VYX $15.34
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- VYX 58.34
- ARWR 46.47
- Support Level
- VYX $11.58
- ARWR $15.19
- Resistance Level
- VYX $12.06
- ARWR $16.06
- Average True Range (ATR)
- VYX 0.38
- ARWR 0.68
- MACD
- VYX -0.03
- ARWR -0.23
- Stochastic Oscillator
- VYX 60.82
- ARWR 15.23
About VYX NCR Voyix Corporation
NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.